Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Skip to content
8-K

SEC Filing Details

Document Details

Form
Filing Date
Jun 8, 2021
Document Date
Jun 7, 2021
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Veracyte, Inc.
Issuer
VERACYTE, INC.